Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
4
×
cancer
4
×
deals
4
×
life sciences
national blog main
national top stories
san diego blog main
san diego top stories
san francisco blog main
startups
4
×
venture capital
4
×
boston blog main
new york blog main
avalon ventures
boulder/denver blog main
boulder/denver top stories
clinical trials
correlation ventures
detroit blog main
detroit top stories
drugs
fda
indiana blog main
indiana top stories
innovation
ipo
laura shawver
medicxi
national
new york top stories
orbimed
ra capital management
raleigh-durham blog main
raleigh-durham top stories
san diego
san francisco top stories
seattle blog main
seattle top stories
synthetic biology
synthorx
What
drugs
advance
bio
biology
cytokine
enhanced
ipo
plans
roundup
san
suite
synthetic
synthorx
acquisitions
ahead
announced
asco
biologic
branded
ceo
choices
collabs
commissioner
company
consumers
costly
counterweight
covid
daniel
deal
demonstrating
diego’s
drug
elevatebio
fda
files
generic
gilead
gilead’s
graft
Language
unset
Current search:
cancer
×
startups
×
" venture capital "
×
biotech
×
deals
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
5 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
Synthorx Files for IPO to Advance Enhanced Cytokine Drugs
@xconomy.com
6 years ago
Synthorx Raises $63M to Advance Suite of Enhanced Cytokine Drugs